NOTE: This test is ONLY AVAILABLE TO AUSTRALIAN RESIDENTS.
The HLA DR/DQ gene analyses two important genomic markers called HLA-DQB1 and HLA-DR that can reveal important information relating to autoimmune disorders as well as inflammatory disorders. It is said that approximately 25% of the world’s population has one of the 10 susceptible types of HLA DR/DQ genes.
The HLA DR/DQ gene test shows haplotypes (gene combinations) that show susceptibility to mold, Lyme, and conditions. The report contains a Rosetta Stone, developed by Dr. Ritchie Shoemaker which offers a summary of the various susceptible genetic types, with directions for interpretation.
About the test kit:
- An authorized blood specimen order form that you take to your local accredited pathology for collection of your blood (Find a pathology near you here).
- A blood specimen test kit for the pathology to use to collect your blood sample
- Complete instructions for taking the test for you and the pathology
- Test results are sent to one of our professional health practitioners within 10-12 business days for evaluation. Our practitioners contact you with the results and recommendations on any findings via email, mail, or phone.
This test is a blood test kit. A test kit will be posted to you with full instructions including prepaid return postage to the laboratory. The following markers will be tested:
HLA-DQB1 and HLA-DR
